Identification of potent siRNA targeting complement C5 and its robust activity in pre-clinical models of myasthenia gravis and collagen-induced arthritis-Reference-Cited by-同舟云学术

Identification of potent siRNA targeting complement C5 and its robust activity in pre-clinical models of myasthenia gravis and collagen-induced arthritis

Published:2023-03 Issue: Volume:31 Page:339-351
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Kuboi Yoshikazu^ORCID,Suzuki Yuta,Motoi Sotaro,Matsui Chiyuki,Toritsuka Naoki,Nakatani Tomoya,Tahara Kazuhiro,Takahashi Yoshinori,Ida Yoko,Tomimatsu Ayaka,Soejima Motohiro,Imai Toshio

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference63 articles.

1. Complement, a target for therapy in inflammatory and degenerative diseases;Morgan;Nat. Rev. Drug Discov.,2015

2. Clinical promise of next-generation complement therapeutics;Mastellos;Nat. Rev. Drug Discov.,2019

3. Complement: a key system for immune surveillance and homeostasis;Ricklin;Nat. Immunol.,2010

4. New insights for C5a and C5a receptors in sepsis;Yan;Front. Immunol.,2012

5. Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab;Peffault de Latour;Blood,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myasthenia gravis: the future is here;Journal of Clinical Investigation;2024-06-17

2. Understanding the Manufacturing Process of Lipid Nanoparticles for mRNA Delivery Using Machine Learning;Chemical and Pharmaceutical Bulletin;2024-06-05

3. The potential application of complement inhibitors-loaded nanosystem for autoimmune diseases via regulation immune balance;Journal of Drug Targeting;2024-03-21

4. Effects of miR-722 on gene expression and alternative splicing in the liver of half-smooth tongue sole after infection with Vibrio anguillarum;Fish & Shellfish Immunology;2024-01

5. Lipid nanoparticle-targeted mRNA formulation as a treatment for ornithine-transcarbamylase deficiency model mice;Molecular Therapy - Nucleic Acids;2023-09